Company Profile

HemoGenix Inc (AKA: HemoGenix LLC)
Profile last edited on: 12/16/16      CAGE: 5FE16      UEI:

Business Identifier: Novel stem-cell and other assays
Year Founded
2000
First Award
2001
Latest Award
2004
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1485 Garden Of The Gods Road Suite 152
Colorado Springs, CO 80907
   (719) 264-6250
   info@hemogenix.com
   www.hemogenix.com
Location: Single
Congr. District: 05
County: El Paso

Public Profile

HemoGenix® specializes in developing in vitro assays used to test the response of stem and progenitor cells from the blood-forming, mesenchymal and other tissues. These assays were initially developed and validated for contract services and then as assay kits which are produced and sold by HemoGenix® for basic research, toxicity testing or quality control. Presently, the HemoGenix patent-protected product line includes numerous assays. HemoGenix also produces related equipment, cell-lines, and other related material. Virtually all the patented and proprietary assays developed by HemoGenix have also been further developed into assay kits for in-house use.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 2 NIH $1,046,630
Project Title: An In Vitro High Throughput Stem Cell Hemotoxicity Assay

Key People / Management

  Ivan N Rich -- President